Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individualized pegylated interferon alfa-2a therapy in chronic hepatitis B
ChiCTR-OCC-12002196Phase 4Completed
- Sponsor
- China-Japan Union Hospital of Jilin University
- Start
- Sep 2005
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of peginterferon alfa-2a, entecavir and adefovir dipivoxil in Chronic Hepatitis B (CHB) (4 arms), sponsored by China-Japan Union Hospital of Jilin University. Primary endpoints: HBV DNA and Quantitative HBsAg. Started Sep 2005; status: completed.
02
Drugs
peginterferon alfa-2aentecaviradefovir dipivoxil
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR-OCC-12002196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OCC-12002196.